David A. Cheresh
Impact in
- Immunology and Allergy top 0.01%
- Cell Adhesion Molecules Research
- Cancer Research top 0.05%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cell Adhesion Molecules Research 157
-
- Protease and Inhibitor Mechanisms 46
- Co-authors
- Peter C. Brooks (16 shared papers)Jay S. Desgrosellier (12 shared papers)Sara M. Weis (44 shared papers)John D. Hood (13 shared papers)Dwayne G. Stupack (25 shared papers)Richard A.F. Clark (1 shared paper)Glen R. Nemerow (12 shared papers)Brian P. Eliceiri (7 shared papers)
- Journals
- The Journal of Cell Biology (28 papers)Journal of Biological Chemistry (22 papers)Proceedings of the National Academy of Sciences (15 papers)Journal of Clinical Investigation (11 papers)Nature Medicine (10 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
David A. Cheresh
253 papers receiving 50.1k citations
David A. Cheresh's Hit Papers
Peers
Comparison fields: 5 of 160
- Immunology and Allergy 18.3k
- Cancer Research 10.3k
- Cell Biology 7.5k
- Molecular Biology 28.1k
- Oncology 9.9k
Countries citing papers authored by David A. Cheresh
This map shows the geographic impact of David A. Cheresh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Cheresh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Cheresh more than expected).
Fields of papers citing papers by David A. Cheresh
This network shows the impact of papers produced by David A. Cheresh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Cheresh. The network helps show where David A. Cheresh may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Cheresh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrins in cancer: biological implications and therapeutic opportunities Hit paper breakdown → | 2009 | 3136 |
| 2 | Requirement of Vascular Integrin α v β 3 for Angiogenesis Hit paper breakdown → | 1994 | 2707 |
| 3 | Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Hit paper breakdown → | 1994 | 2055 |
| 4 | Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Hit paper breakdown → | 1993 | 1935 |
| 5 | Tumor angiogenesis: molecular pathways and therapeutic targets Hit paper breakdown → | 2011 | 1497 |
| 6 | Role of integrins in cell invasion and migration Hit paper breakdown → | 2002 | 1477 |
| 7 | Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 Hit paper breakdown → | 1996 | 1394 |
| 8 | Definition of Two Angiogenic Pathways by Distinct α v Integrins Hit paper breakdown → | 1995 | 1181 |
| 9 | Regulation of Cell Motility by Mitogen-activated Protein Kinase Hit paper breakdown → | 1997 | 1122 |
| 10 | 2005 | 765 | |
| 11 | Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging Hit paper breakdown → | 1998 | 762 |
| 12 | Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. Hit paper breakdown → | 1995 | 754 |
| 13 | 2002 | 736 | |
| 14 | Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability Hit paper breakdown → | 1999 | 702 |
| 15 | 1998 | 607 | |
| 16 | Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance Hit paper breakdown → | 2015 | 576 |
| 17 | 1999 | 570 | |
| 18 | 1998 | 541 | |
| 19 | 1987 | 539 | |
| 20 | 2008 | 537 |
About David A. Cheresh
David A. Cheresh is a scholar working on Immunology and Allergy, Cancer Research, Molecular Biology, Immunology and Hematology, having authored 255 papers that have together received 52.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (157 papers), Angiogenesis and VEGF in Cancer (59 papers), Protease and Inhibitor Mechanisms (46 papers), Monoclonal and Polyclonal Antibodies Research (36 papers), Glycosylation and Glycoproteins Research (28 papers), Platelet Disorders and Treatments (25 papers), Cellular Mechanics and Interactions (25 papers) and Cancer Cells and Metastasis (12 papers). The work is most often cited by research in Immunology and Allergy (18.3k citations), Cancer Research (10.3k citations), Cell Biology (7.5k citations), Molecular Biology (28.1k citations) and Oncology (9.9k citations). David A. Cheresh has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Peter C. Brooks, Jay S. Desgrosellier, Sara M. Weis, John D. Hood, Dwayne G. Stupack, Richard A.F. Clark, Glen R. Nemerow, Brian P. Eliceiri, Richard L. Klemke and Ralph A. Reisfeld. Their work appears in journals such as The Journal of Cell Biology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.